Comparison

(1α,1'S,4β)-Lanabecestat European Partner

Item no. HY-100740C-2mg
Manufacturer MedChem Express
CASRN 1384082-96-5
Amount 2mg
Quantity options 100 mg 10mM/1mL 10 mg 2mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 96.01
Citations [1]Eketjäll S, et al. AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics. J Alzheimers Dis. 2016;50(4):1109-23.
Smiles NC(C(C)=N1)=N[C@]21C3=C(C=CC(C4=CC(C#CC)=CN=C4)=C3)C[C@]52CC[C@@H](OC)CC5
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias (1α,1'S,4β)-AZD3293; (1α,1'S,4β)-LY3314814
Available
Product Description
(1α, 1'S, 4β)-Lanabecestat ((1α, 1'S, 4β)-AZD3293) a less active enantiomer of Lanabecestat. Lanabecestat is a potent, orally active and blood-brain barrier penetrating BACE1 inhibitor with a Ki of 0.4 nM[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Neuroscience-Neurodegeneration
MolecularWeight
412.53
Clinical_Information
No Development Reported
Manufacturers Research Area
Neurological Disease
Solubility
DMSO : 250 mg/mL (ultrasonic)
Manufacturers Target
Beta-secretase
Isoform
BACE1
Pathway
Neuronal Signaling

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 2mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close